Search

CMS Medicare Part C/D Reporting Requirements Notice Comment Period

The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on its intention to collect information related to Medicare Part C and D reporting requirements. This notice provides a 60-day comment period for interested parties to submit feedback on the proposed information collection.

CMS Seeks Public Comment on Information Collection Activities

The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on its intention to collect information from the public under the Paperwork Reduction Act. This notice provides an opportunity for interested parties to submit comments on the proposed information collection activities.

Medicare Drug Price Negotiation: Manufacturer Participation in Third Cycle

CMS announced that 15 drug manufacturers have chosen to participate in the third cycle of Medicare drug price negotiations. These negotiations, part of the Inflation Reduction Act, will determine prices for selected high-expenditure drugs, with negotiated prices effective beginning in 2028.

CMS Extends GENEROUS Model Application Deadline

The Centers for Medicare & Medicaid Services (CMS) has extended the application deadline for the GENEROUS Model, a drug pricing initiative for Medicaid, from March 31, 2026, to April 30, 2026. This extension provides additional time for prescription drug manufacturers to apply to participate in the model, which aims to lower drug spending and improve health outcomes.

Medicare.gov Enhanced Login Options

The Centers for Medicare & Medicaid Services (CMS) has introduced new login options for Medicare.gov, including ID.me, CLEAR, and Login.gov, to enhance user security and protect beneficiary information from fraud and identity theft. These services are free and offer various verification and support methods.